Janux Therapeutics, Inc. (JANX)

NGM – Real Time Price. Currency in USD

16.58

+0.06 (0.36%)

Market open: Aug 12, 2026, 10:19 AM EDT

16.52

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics, Inc. (JANX) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.55 per share a year ago.

06.08.2026

Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today reported financial results for the quarter ended June 30, 2026, and provided a business update. "During the second quarter we continued to execute across our clinical portfolio while preparing for multiple upcoming milestones," said David Campbell, Ph.D., President and Chief Executive Officer of Janux. "Enrollment con.

Videos

No Data

There is no data to display

Press releases

06.08.2026

Janux Therapeutics, Inc. (JANX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Janux Therapeutics, Inc. (JANX)

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

Videos

No Data

Press releases

Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

Videos

No Data

Press releases

Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

Search stocks

Janux Therapeutics, Inc. (JANX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Janux Therapeutics, Inc. (JANX)

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

Videos

No Data

Press releases

Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

Videos

No Data

Press releases

Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights